Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source, enhances the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness.
Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Our core technologies are built upon the multinozzle emitter array (MEA) technology, invented from the Lawrence Berkeley National Laboratory (Berkeley Lab), which has won the 2012 R&D 100 award.
Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Our core technologies are built upon the multinozzle emitter array (MEA) technology, invented from the Lawrence Berkeley National Laboratory (Berkeley Lab), which has won the 2012 R&D 100 award.
Location: United States, California, Berkeley
Employees: 11-50
Total raised: $7.9M
Founded date: 2011
Investors 3
| Date | Name | Website |
| 26.01.2021 | LDV Partne... | ldvp.com |
| - | Berkeley C... | berkeleyca... |
| - | SVE Capita... | sve-capita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.12.2020 | Series B | $7.9M | - |
Mentions in press and media 3
| Date | Title | Description |
| 02.12.2020 | Daily funding roundup - Dec. 1st, 2020 | WaveOne has raised $6.5M; Databand landed $14.5M; Proscia has secured $23M Reposite: Reposite is a New York-based maker of a database that helps travel agents manage suppliers and clients, track proposals. Reposite and better manage their b... |
| 01.12.2020 | Newomics Raises $7.9M in Series B Financing | Newomics Inc., a Berkeley, Calif.-based biotechnology company developing and commercializing mass spectrometry solutions for molecular detection applications, closed a $7.9m Series B financing. The round was led by MSA Capital with particip... |
| 01.12.2020 | Newomics Secures $7.9M Series B Round | BERKELEY, CA, Newomics today announced the closing of their $7.9 million Series B financing. >> Click here for more funding data on Newomics >> To export Newomics funding data to PDF and Excel, click here Newomics, a biot... |